DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cancer Research

• Publication date

  1997-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9157982
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21

  1996cited by this paper
• Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene‐mediated apoptosis.

  1996cited by this paper
• Regulation of Apoptosis Induced by the Retinoid N-(4-Hydroxyphenyl) Retinamide and Effect of Deregulated bcl-2

  1995cited by this paper
• Specific DNA binding by different classes of human p53 mutants.

  1995cited by this paper
• Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.

  1995cited by this paper
• Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2.

  1995cited by this paper
• Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

  1995cited by this paper
• A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53–deficient mice

  1995cited by this paper
• Epstein‐Barr virus efficiently immortalizes human B cells without neutralizing the function of p53.

  1995cited by this paper
• Irradiation Induces WAF1 Expression through a p53-independent Pathway in KG-1 Cells (*)

  1995cited by this paper
• Genomic stability and wild-type p53 function of lymphoblastoid cells with germ-line p53 mutation.

  1995cited by this paper
• A p53-dependent mouse spindle checkpoint

  1995cited by this paper
• Clonal expansion of p53 mutant cells in leukemia progression in vitro.

  1994cited by this paper
• WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

  1994cited by this paper
• Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

  1994cited by this paper
• Monoclonal Antibody against PRADl/Cyclin Dl Stains Nuclei of Tumor Cells with Translocation or Amplification at BCL‐1 Locus

  1994cited by this paper
• Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation.

  1994cited by this paper
• Mouse p53 represses the rat brain creatine kinase gene but activates the rat muscle creatine kinase gene

  1994cited by this paper
• p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes

  1994cited by this paper
• Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency

  1994cited by this paper
• p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation.

  1994cited by this paper
• p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

  1994cited by this paper
• Mutant p53 proteins behave in a dominant, negative fashion in vivo.

  1994cited by this paper
• Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53.

  1993cited by this paper
• EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

  1993cited by this paper
• Screening patients for heterozygous p53 mutations using a functional assay in yeast

  1993cited by this paper
• Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.

  1993cited by this paper
• A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm.

  1993cited by this paper
• p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.

  1993cited by this paper
• Germ-line p53 mutation is uncommon in patients with triple primary cancers.

  1993cited by this paper
• Control of G1 arrest after DNA damage.

  1993cited by this paper
• Oncogenic forms of p53 inhibit p53-regulated gene expression.

  1992cited by this paper
• A functional screen for germ line p53 mutations based on transcriptional activation.

  1992cited by this paper
• Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome.

  1992cited by this paper
• Association of human cyclin E with a periodic G1-S phase protein kinase.

  1992cited by this paper
• Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma.

  1992cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991cited by this paper
• Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

  1990cited by this paper
• Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome

  1990cited by this paper
• Human blymphocytes immortalization by epstein-barr virus in the presence of cyclosporin a

  1986cited by this paper

• Genetic profiling of mammary periductal stromal tumors with histologic correlation highlights high-grade and low-grade groups and similarities to phyllodes tumors.

  2026cites this paper
• The dynamic role of nucleoprotein SHCBP1 in the cancer cell cycle and its potential as a synergistic target for DNA-damaging agents in cancer therapy

  2024cites this paper
• Alternative approaches to overcome chemoresistance to apoptosis in cancer.

  2021cites this paper
• Enhancement of Annexin V in response to combination of epigallocatechin gallate and quercetin as a potent arrest the cell cycle of colorectal cancer.

  2021cites this paper
• The Challenge of Combining Chemo- and Radiotherapy with Checkpoint Kinase Inhibitors

  2020cites this paper
• In cis TP53 and RAD51C pathogenic variants may predispose to sebaceous gland carcinomas

  2020cites this paper
• Ultraviolet A Eye Irradiation Ameliorates Atopic Dermatitis via p53 and Clock Gene Proteins in NC/Nga Mice

  2018cites this paper
• Quantitative Phosphoproteomics Reveals Wee1 Kinase as a Therapeutic Target in a Model of Proneural Glioblastoma

  2016cites this paper
• Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma

  2015cites this paper
• Cold-inducible RNA-binding protein, CIRP, inhibits DNA damage-induced apoptosis by regulating p53.

  2015cites this paper
• Genetic and molecular alterations in pancreatic cancer: Implications for personalized medicine

  2013cites this paper
• Drastic Effect of Germline TP53 Missense Mutations in Li–Fraumeni Patients

  2013cites this paper
• Number of rare germline CNVs and TP53 mutation types

  2012cites this paper
• Functional studies of a novel Germline p53 splicing mutation identified in a patient with Li–Fraumeni‐Like syndrome

  2012cites this paper
• The Novel Function of OCT4B Isoform‐265 in Genotoxic Stress

  2012cites this paper
• Glioblastoma: Germline Mutation of TP53

  2011cites this paper
• MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer Xenografts

  2011cites this paper
• Li-fraumeni syndrome.

  2011cites this paper
• Adrenocortical carcinoma

  2010cites this paper
• Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor

  2009cites this paper
• Syndrome de Li-Fraumeni

  2009cites this paper
• Elucidation of the epigenetic code of the chromosomal region 13q14.3 in Chronic Lymphocytic Leukemia (CLL)

  2009cites this paper
• Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.

  2008cites this paper
• High resolution melting for mutation scanning of TP53 exons 5–8

  2007cites this paper
• p53 in Human Cancer — Somatic and Inherited Mutations and Mutation-independent Mechanisms

  2005cites this paper
• Immunocytochemical detection of members of the caspase cascade of apoptosis in childhood medulloblastomas.

  2005cites this paper
• The p53 Tumor Suppressor Pathway and Cancer

  2005cites this paper
• DNA damage-induced cell-cycle phase regulation of p53 and p21waf1 in normal and ATM-defective cells

  2003cites this paper
• Expression of Apoptosis-related Antigens, Fas, bcl-2, and p53, and Mib-1 Proliferation Index in the Hypoplastic Thymus of DiGeorge Syndrome

  2002cites this paper
• p53 transgenic mice are highly susceptible to 1, 2-dimethylhydrazine-induced uterine sarcomas.

  2002cites this paper
• Telomerase Protects Cancer-Prone Human Cells from Chromosomal Instability and Spontaneous Immortalization

  2002cites this paper
• The significance of immunohistochemistry in the diagnosis and therapy of neoplasms

  2002cites this paper
• Genetic alterations in ovarian cancer cells that might account for sensitivity to chemotherapy in patients.

  2002cites this paper
• Molecular mechanisms of tumour suppression by the P53-stabilizing compound CP-31398

  2002cites this paper
• Genetic background as a possible determinant of clinical and biological features of Epstein-Barr virus infection--a hypothetical view.

  2002cites this paper
• p 53 Transgenic Mice Are Highly Susceptible to 1 , 2-Dimethylhydrazine-induced Uterine Sarcomas 1

  2002cites this paper
• The C-terminus of mutant p53 is necessary for its ability to interfere with growth arrest or apoptosis

  2001cites this paper
• The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI

  2001cites this paper
• Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.

  2001cites this paper
• Induction of apoptosis by a Newcastle disease virus vaccine (MTH-68/H) in PC12 rat phaeochromocytoma cells.

  2001cites this paper
• [Li-Fraumeni syndrome: update, new data and guidelines for clinical management].

  2001cites this paper
• Immunocytochemical detection of leukocyte-associated and apoptosis-related antigen expression in childhood brain tumors.

  2001cites this paper
• P53 and hMSH2 expression in basal cell carcinomas and malignant melanomas from photoexposed areas of head and neck region.

  2001cites this paper
• Germ-line p 53 Mutations Predispose to a Wide Spectrum of Early-onset Cancers 1

  2001cites this paper
• Human Cancer Genetics

  2001cites this paper
• Regulation of tumor cell apoptotic sensitivity during the cell cycle (Review).

  2000cites this paper
• The role of apoptosis in normal ontogenesis and solid human neoplasms.

  2000cites this paper
• sources and effects of ionizing radiation

  2000cites this paper
• p53 Deficiency Increases Transformation by v-Abl and Rescues the Ability of a C-Terminally Truncated v-Abl Mutant To Induce Pre-B Lymphoma In Vivo

  2000cites this paper
• Spontaneous neoplastic regression: the significance of apoptosis.

  2000cites this paper
• Human TP53 from the Malignant Glioma-Derived Cell Lines M059J and M059K Has a Cancer-Associated Mutation in Exon 8

  2000cites this paper
• Cell cycle progression and apoptosis after irradiation in an acidic environment

  2000cites this paper
• Mechanisms of p53-induced apoptosis.

  1999cites this paper
• The dual role model for p53 in maintaining genomic integrity

  1999cites this paper
• Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?

  1999cites this paper
• Defective control of apoptosis and mitotic spindle checkpoint in heterozygous carriers of ATM mutations.

  1999cites this paper
• γ‐Irradiation Deregulates Cell Cycle Control and Apoptosis in Nevoid Basal Cell Carcinoma Syndrome‐derived Cells

  1999cites this paper
• Use of a yeast assay to detect functional alterations in p53 in prostate cancer: Review and future directions

  1999cites this paper
• DNA damage-associated cell cycle and cell death control is differentially modulated by caffeine in clones with p53 mutations

  1999cites this paper
• The need for dynamic methods for measuring cell cycle perturbations: a study in radiation‐treated lymphoblastoid cell lines of varying p53 status

  1999cites this paper
• Inhibition of telomerase limits the growth of human cancer cells

  1999cites this paper
• Fas (APO-1, CD95) receptor expression and new options for immunotherapy in childhood medulloblastomas.

  1999cites this paper
• Defective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia.

  1998cites this paper
• Li-Fraumeni syndrome and the role of the p53 tumor suppressor gene in cancer susceptibility.

  1998cites this paper
• p53-dependent cell cycle control: response to genotoxic stress.

  1998cites this paper
• Cell cycle arrest following exposure of EBV‐immortalised B‐cells to gamma irradiation correlates with inhibition of cdk2 activity

  1998cites this paper
• 神経芽腫と網膜芽腫を合併した 1 男児例

  1998cites this paper
• Recent advances in the study of the hereditary and environmental basis of childhood leukemia.

  1998cites this paper
• Analysis of cell cycle check point and apoptosis induction in Ataxia Telangiectasia

  1998cites this paper
• Gene therapy for lung cancer.

  1998cites this paper
• Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions.

  1998cites this paper
• Effect of simian virus large T antigen expression on cell cycle control and apoptosis in rat pleural mesothelial cells exposed to DNA damaging agents

  1998cites this paper
• 14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression

  1997cites this paper
• 14-3-3sigma is a p53-regulated inhibitor of G2/M progression.

  1997cites this paper
• Mechanisms of induction of skin cancer by UV radiation.

  1997cites this paper
• International Journal of Women's Health Dovepress Medical Factors Influencing Decision Making regarding Radiation Therapy for Breast Cancer

  year unknowncites this paper